ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NVRO Nevro Corp

14.41
-0.01 (-0.07%)
Last Updated: 09:52:27
Delayed by 15 minutes

Period:

Draw Mode:

Volume 10,778
Bid Price
Ask Price
News -
Day High 14.49

Low
13.36

52 Week Range

High
39.675

Day Low 14.28
Company Name Stock Ticker Symbol Market Type
Nevro Corp NVRO NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.07% 14.41 09:52:27
Open Price Low Price High Price Close Price Prev Close
14.40 14.28 14.49 14.42
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
141 10,778 $ 14.38 $ 154,996 - 13.36 - 39.675
Last Trade Time Type Quantity Stock Price Currency
09:52:27 1 $ 14.48 USD

Nevro Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
524.86M 36.40M - 425.17M -92.21M -2.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Nevro News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVRO Message Board. Create One! See More Posts on NVRO Message Board See More Message Board Posts

Historical NVRO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.2314.5413.3913.81293,1970.181.26%
1 Month14.9515.9813.3614.29451,103-0.54-3.61%
3 Months19.1621.6613.3616.55494,303-4.75-24.79%
6 Months19.1522.6413.3617.31543,136-4.74-24.75%
1 Year32.8339.67513.3621.58548,661-18.42-56.11%
3 Years137.25182.4513.3658.57549,214-122.84-89.50%
5 Years62.02188.1413.3676.37492,839-47.61-76.77%

Nevro Description

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.

Your Recent History

Delayed Upgrade Clock